Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Tanji

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Biochemical and Biophysical Research Communications|November 30, 1994
Production of two phosphoproteins from the NS5A region of the hepatitis C viral genomeT Kaneko, Y Tanji, S Satoh, et al.
Angiology|September 1, 1990
Successful direct PTCA on LAD after first episode of acute myocardial infarction: does it improve cardiac function?H Asonuma, Y Tanji, H Nakatoh, et al.
Photomedicine and Laser Surgery|May 25, 2005
Intrapulpal temperature during preparation with the Er:YAG laser: an in vitro studyVinícius R Geraldo-Martins, Edgar Y Tanji, Niklaus U Wetter, et al.
Surgery Today|May 20, 1999
Ovarian carcinoma with fistula formation to the sigmoid colon and ileum: report of a caseS J Kim, Y Kimoto, H Nakamura, et al.
Archives of Virology|January 1, 1993
Two proteinase activities in HCV polypeptide expressed in insect cells using baculovirus vectorY Hirowatari, M Hijikata, Y Tanji, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 1993
Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virusM Hijikata, H Mizushima, Y Tanji, et al.
Anticancer Research|March 1, 1997
Urokinase type plasminogen activator receptor is a novel prognostic factor in breast cancerS J Kim, E Shiba, T Taguchi, et al.
Anticancer Research|May 1, 1997
Thrombomodulin is a new biological and prognostic marker for breast cancer: an immunohistochemical studyS J Kim, E Shiba, H Ishii, et al.
Oncology Reports|April 18, 1998
The expression of urokinase type plasminogen activator is a novel prognostic factor in dukes B and C colorectal cancerS J Kim, E Shiba, F Tsukamoto, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2003
Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer riskY Miyoshi, A Ando, S Hasegawa, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Biochemical and Biophysical Research Communications|November 30, 1994
Production of two phosphoproteins from the NS5A region of the hepatitis C viral genomeT Kaneko, Y Tanji, S Satoh, et al.
Angiology|September 1, 1990
Successful direct PTCA on LAD after first episode of acute myocardial infarction: does it improve cardiac function?H Asonuma, Y Tanji, H Nakatoh, et al.
Photomedicine and Laser Surgery|May 25, 2005
Intrapulpal temperature during preparation with the Er:YAG laser: an in vitro studyVinícius R Geraldo-Martins, Edgar Y Tanji, Niklaus U Wetter, et al.
Surgery Today|May 20, 1999
Ovarian carcinoma with fistula formation to the sigmoid colon and ileum: report of a caseS J Kim, Y Kimoto, H Nakamura, et al.
Archives of Virology|January 1, 1993
Two proteinase activities in HCV polypeptide expressed in insect cells using baculovirus vectorY Hirowatari, M Hijikata, Y Tanji, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 1993
Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virusM Hijikata, H Mizushima, Y Tanji, et al.
Anticancer Research|March 1, 1997
Urokinase type plasminogen activator receptor is a novel prognostic factor in breast cancerS J Kim, E Shiba, T Taguchi, et al.
Anticancer Research|May 1, 1997
Thrombomodulin is a new biological and prognostic marker for breast cancer: an immunohistochemical studyS J Kim, E Shiba, H Ishii, et al.
Oncology Reports|April 18, 1998
The expression of urokinase type plasminogen activator is a novel prognostic factor in dukes B and C colorectal cancerS J Kim, E Shiba, F Tsukamoto, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2003
Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer riskY Miyoshi, A Ando, S Hasegawa, et al.
Pageof 6